Role of microRNA in chronic lymphocytic leukemia onset and progression

MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia

(2014) B. Cui et al.   BLOOD

Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia

(2014) A Veronese et al.   LEUKEMIA

Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia

(2013) A. Ferrajoli et al.   BLOOD

Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia

(2013) D Allegra et al.   LEUKEMIA

MicroRNAs and B cell receptor signaling in chronic lymphocytic leukemia

(2013) Marek Mraz et al.   LEUKEMIA & LYMPHOMA

B-cell malignancies in microRNA E -miR-17 92 transgenic mice

(2013) S. K. Sandhu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MicroRNAs regulate B-cell receptor signaling-induced apoptosis

(2012) J L Kluiver et al.   GENES AND IMMUNITY

The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes

(2012) R Bomben et al.   LEUKEMIA

miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia

(2011) R. Visone et al.   BLOOD

Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic Leukemia

(2011) Muller Fabbri   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

MicroRNAs in body fluids—the mix of hormones and biomarkers

(2011) Maria Angelica Cortez et al.   Nature Reviews Clinical Oncology

MicroRNA Expression Profiling Identifies Activated B Cell Status in Chronic Lymphocytic Leukemia Cells

(2011) Shuqiang Li et al.   PLoS One

microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival

(2010) S. Rossi et al.   BLOOD

The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia

(2010) Ulf Klein et al.   CANCER CELL

Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemia

(2010) Olaf Merkel et al.   CELL CYCLE

Genetic lesions in chronic lymphocytic leukemia: what's ready for prime time use?

(2010) C. Moreno et al.   HAEMATOLOGICA

miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines

(2010) Wei Zhu et al.   INTERNATIONAL JOURNAL OF CANCER

MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia

(2010) Manuela Ferracin et al.   Molecular Cancer

Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression

(2010) U. Santanam et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial

(2009) T. Zenz et al.   BLOOD

miR-34a as part of the resistance network in chronic lymphocytic leukemia

(2008) T. Zenz et al.   BLOOD

Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes

(2008) Changchun Xiao et al.   NATURE IMMUNOLOGY

MiR-15a and miR-16-1 cluster functions in human leukemia

(2008) George A. Calin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA